Mindfulness-based cognitive therapy for individuals whose lives have been affected by cancer: a randomized controlled trial. 


Author: Foley E, Baillie A, Huxter M, Price M, Sinclair E.  

Affiliation: Cancer Institute NSW and Department of Psychology, Macquarie University, Sydney, New South Wales, Australia. elizabeth@mindpotential.com.au 
Conference/Journal: J Consult Clin Psychol.
Date published: 2010 Feb
Other:
 Volume ID: 78   ,  Issue ID: 1   ,  Pages: 72-9   ,  Word Count: 193  
    OBJECTIVE: This study evaluated the effectiveness of mindfulness-based cognitive therapy (MBCT) for individuals with a diagnosis of cancer. METHOD: Participants (N = 115) diagnosed with cancer, across site and stage, were randomly allocated to either the treatment or the wait-list condition. Treatment was conducted at 1 site, by a single therapist, and involved participation in 8 weekly 2-hr sessions that focused on mindfulness. Participants meditated for up to 1 hr daily and attended an additional full-day session during the course. Participants were assessed before treatment and 10 weeks later; this second assessment occurred immediately after completion of the program for the treatment condition. The treatment condition was also assessed at 3 months postintervention. All postinitial assessments were completed by assessors who were blind to treatment allocation. RESULTS: There were large and significant improvements in mindfulness (effect size [ES] = 0.55), depression (ES = 0.83), anxiety (ES = 0.59), and distress (ES = 0.53) as well as a trend for quality of life (ES = 0.30) for MBCT participants compared to those who had not received the training. The wait-list group was assessed before and after receiving the intervention and demonstrated similar change. CONCLUSIONS: These improvements represent clinically meaningful change and provide evidence for the provision of MBCT within oncology settings.